Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Dec;86(12):1216-23.
doi: 10.1111/j.1349-7006.1995.tb03318.x.

Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment

Affiliations
Comparative Study

Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment

T Kamigaki et al. Jpn J Cancer Res. 1995 Dec.

Abstract

Recombinant mouse/human chimeric monoclonal antibody A10 (ch-A10) and its Fab fragment (ch-Fab) react with carcinoembryonic antigen on various gastrointestinal carcinomas. We performed biodistribution studies with 125I-labeled ch-A10 and ch-Fab in an antigen-positive human pancreatic carcinoma (BxPC-3) xenograft model. We also evaluated the anti-tumor effect of 131I-labeled ch-A10, and studied the detection of BxPC-3 xenografts with 123I-labeled ch-Fab in whole body scintigraphy. In comparative biodistribution studies, the tumor uptake of 125I-labeled ch-A10 was significantly greater than that of 125I-labeled ch-Fab 24 h post-injection. However, the tumor-to-blood ratio was 46.8 for ch-Fab at 24 h post-injection, while it was only 1.4 for ch-A10. Microautoradiography studies showed that ch-Fab penetrated more uniformly into the tumor nodules than did ch-A10. In mice given a therapeutic dose of 131I-labeled ch-A10, a significant inhibition of tumor growth was seen, while control 131-I-labeled human IgG did not affect tumor growth. Leukocyte toxicity was observed within 3 weeks after injection of 131I-labeled ch-A10, but leukocyte counts recovered to normal levels at 8 weeks post-injection. In whole-body scintigraphy, clear and rapid tumor imaging was obtained with 200 microCi of 123I-labeled ch-Fab 24 h post-injection. These results suggest that radioiodine-labeled chimeric A10 antibodies could potentially be useful candidates for radioimmunotherapy and radioimmunodetection of pancreatic carcinomas.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Begent , R. H. J. , Ledermarm , J. A. , Green , K. D. , Bagshawe , S. J. , Riggs , F. , Searle , F. , Keep , P. A. , Adam , T. , Dale , R. G , and Glaser , M. G.Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer . Br. J. Cancer , 60 , 406 – 412 ( 1989. ). - PMC - PubMed
    1. ) Breitz , H. B. , Weiden , P. L. , Vanderheyden , J.‐L. , Appelbaum , J. W. , Bjorn , M. J. , Fer , M. F. , Wolf , S. B. , Ratliff , B. A. , Seiler , C. A. , Foisie , D. C. , Fisher , D. R. , and Shoroff , R. W.Clinical experience with rhenium‐186‐labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials . J. Nucl. Med. , 33 , 1099 – 1112 ( 1992. ). - PubMed
    1. ) Carrasquillo , J. A. , Sugarbaker , P. , Colcher , D. , Reynolds , J. C. , Esteban , J. , Bryant , G. , Keenan , A. M. , Perentesis , P. , Yokoyama , K. , Simpson , D. E. , Ferroni , P. , Farkas , R. , Schlom , J. and Larson , S. M.Radioimmunoscintigra‐phy of colon cancer with iodine‐131‐labeled B72.3 monoclonal antibody. J . Nucl Med. , 29 , 1022 – 1030 ( 1988. ). - PubMed
    1. ) Halpen , S. E. , Haindl , W. , Beauregard , J. , Hagen , P. , Clutter , M. , Amox , D. , Merchant , B. , Unger , M. , Mongovi , C. , Bartholomew , R. , Jue , R. , Carlo , D. and Dillman , R.Scintigraphy with In‐ill‐labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection . Radiology , 168 , 529 – 536 ( 1988. ). - PubMed
    1. ) Brown , B. A. , Dearborn , C. B. , Drozynski , C. A. and Sands , H.Pharmacokinetics of 99mTc‐metallothionein‐B72.3 and its F(ab')2 fragment . Cancer Res. 50 ( Suppl ), 835s – 839s ( 1990. ). - PubMed

Publication types

MeSH terms

LinkOut - more resources